Company page

Innate Pharma Sa Class A

Innate Pharma Sa Class A, traded under the ticker IPH, is a public company based in France. The company has a market capitalization of approximately €170.86 million. Innate Pharma focuses on developing innovative immunotherapies for cancer treatment.